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B. Protein Expression and Purification
HaloTag-mLin28A cloning. Murine Lin28A was amplified from a pETDuet vector and ligated into pFN29k using standard cloning techniques with SgfI and PmeI restriction enzymes.
Primers:
5' AGTCAGCGATCGCTTCAGGCTCGGTGTCCAACCAGC 5' AAACCTTTTCAATTCTGGGCTTCTGGGAGC HaloTag-mLin28A expression and purification. E. coli transformed with pFN29K HaloTag-mLin28A were grown at 37 °C to an OD 600 of 0.6 and induced with IPTG (500 µM) overnight at 37 °C. Cells were pelleted for 15 min at 3,000×g, suspended in phosphate-buffered saline (100 mM phosphate buffer (pH 7), 150 mM NaCl), centrifuged again for 15 min at 3000×g, and stored as pellets at -80 °C until needed. Pellets were thawed at 25 °C on ice before being lysed via sonication at 4 °C in lysis buffer containing 20 mM imidazole (pH 8), 10 mM phosphate, 2.7 mM KCl, 137 mM NaCl, 0.1% PMSF and 1 mM DTT. Lysates were then centrifuged at 3000×g for 30 min at 4 °C. The supernatant was subsequently applied to Ni-NTA resin and washed twice (1× in lysis buffer; 1× in 50:50 lysis buffer/wash buffer (10 mM Tris (pH 8), 50 mM imidazole, 500 mM NaCl, 0.1% PMSF, 1 mM DTT).
HaloTag-mLin28A was eluted in 10 mM Tris (pH 8), 500 mM imidazole, 500 mM NaCl, 0.1% PMSF, 1 mM DTT, before being dialyzed overnight into 20 mM Tris (pH 7.8), 100 mM KCl, 0.2 mM EDTA, 10% glycerol (v/v). Protein concentrations were determined by the Bradford assay using BSA standards.
HaloTag-Lin28B cloning. Human Lin28B was amplified from A549 cDNA and ligated into pFC30K vector using standard cloning techniques with SgfI and EcoIRCI restriction enzymes. cDNA was prepared using Superscript III first strand synthesis kit (Invitrogen).
Primers: 5' AGCTGCGATCGCAATGGCCGAAGGCGGGGC 5' AGCTGAGCTCTTGTCTTTTTCCTTTTTTGAACTGAAGG
HaloTag-Lin28B expression and purification. E. coli transformed with pFN30K HaloTag-Lin28B were grown at 37 °C to an OD 600 of 0.8 and induced with IPTG (500 µM) overnight at 37 °C. Cells were pelleted at 4 °C for 15 min at 3,000×g, suspended in phosphate-buffered saline (100 mM phosphate buffer (pH 7), 150 mM NaCl), centrifuged again for 15 min at 3,000×g, and stored as pellets at -80 °C until needed. Pellets were thawed at 25 °C on ice before being lysed via sonication at 4 °C in lysis buffer containing 20 mM imidazole (pH 8), 10 mM phosphate, 2.7 mM KCl, 137 mM NaCl, 0.1% PMSF and 1 mM DTT. Lysates were then centrifuged at 3,000×g for 30 min at 4 °C. The supernatant was subsequently applied to Ni-NTA resin and washed twice (1× in lysis buffer; 1× in 50:50 lysis buffer/wash buffer (10 mM Tris (pH 8), 50 mM imidazole, 500 mM NaCl, 0.1% PMSF, 1 mM DTT). HaloTag-Lin28B was eluted in 10 mM Tris (pH 8), 500 mM imidazole, 500 mM NaCl, 0.1% PMSF, 1 mM DTT, before being dialyzed overnight into 20 mM Tris (pH 7.8), 100 mM KCl, 0.2 mM EDTA, 10% glycerol (v/v). Lin28B was concentrated using an Amicon Ultra-15 centrifugal filter unit (10 kDa cut-off), and the protein was stored in 20 mM Tris (pH 7.8), 100 mM KCl, 0.2 mM EDTA, 10% glycerol (v/v) and 2 mM of DTT. Protein concentrations were determined by the Bradford assay using BSA standards. 5'-amino-modified pre-let-7d (1.0 mM in 100 mM phosphate buffer, pH 8.0) was mixed with an equivalent volume of TCO-PEG4-NHS (10 mM in DMSO). The reaction was then allowed to proceed at 25 °C for 1 h. pre-let-7d-TCO was precipitated by the addition of 1.1× volume of 3.0 M sodium acetate (pH 5.2) and 40 volume equivalents of cold ethanol, and pelleted at 20,000 × g for 40 min at 4 °C. The pellet was then suspended in 100 mM phosphate buffer (pH 8.0) at a concentration of 1.0 mM and stored at -80 °C.
Confirmation of pre-let-7d−Lin28 binding via EMSA.
32 P: A microcentrifuge tube was charged with the following in this order: 4 µL H 2 O, 1 µL 10× T4 polynucleotide kinase (PNK) buffer, 5 µL of a 100 µM stock of pre-let-7d (5'-AGAGGUAGUAGGU UGCAUAGUUUUAGGGCAGGGAUUUUGCCCACAAGGAGGUAACUAUACGACCUGCUGCC UUUCU-3'), 1 µL T4 PNK, and 5 µL of 3.33 µM stock of 32 P-γ-ATP (approximately 8.6 mCi/mL). The labeling reaction was allowed to progress at 37 °C for 30 min before 4 µL of 121 µM cold ATP was added. The mixture was subsequently incubated for an additional 30 min at 37 °C. PNK was then inactivated by heat denaturation at 70 °C for 15 min. The RNA was diluted to 4 nM in binding buffer (50 mM Tris (pH 7.6), 150 mM NaCl, 5% glycerol, 0.05% Tween-20; freshly dissolved and added 1 mM ZnCl 2 and 10 mM β-mercaptoethanol) containing various concentrations of biotinylated HaloTagmLin28A in 4 µL-reaction volumes. After incubation at 25 °C for 30 min, the reaction was mixed with 4 µL of loading buffer (binding buffer supplemented with additional 10% glycerol and trace bromophenol blue and xylene cyanol for color) and run on an 8% native TBE gel.
32 P was exposed to a phosphorimaging plate and quantified by a Typhoon Phosphoimager.
SYBR Gold: TCO-labeled pre-let-7d (10 µL of a 500 nM stock) and HaloTag-mLin28A were mixed with DMSO or compound in binding buffer (50 mM Tris (pH 7.6), 150 mM NaCl, 5% glycerol (v/v), 0.05% Tween-20, and fresh 1 mM ZnCl 2 and 10 mM β-mercaptoethanol). All samples were subsequently adjusted to 5% DMSO final concentration. The mixture was then incubated at 25 °C for 30 min before 10 µL of loading dye. The samples were then loaded on 8% native TBE gels and run in TBE buffer before being stained with SYBR Gold for 5 min. Gels were then imaged on a Protein Simple gel imager using the multiflour green setting. HTS data analysis. HTS data were monitored and analyzed using MScreen. 
F. Synthetic Methods
General synthetic method. The synthesis of N,N'-(1,2-phenylene)dibenzenesulfonamides was carried out by dissolving the corresponding diamine (1.0 equiv) in dry dichloromethane (2 mL), and subsequently cooling the reaction to 0 °C using an ice bath. After 5 min, pyridine (2.4 equiv) and aryl sulfonyl chloride (dropwise, 2.4 equiv) were added, and the resultant mixture was stirred at 25 °C for 12 h. The reaction was then quenched with water (~5 mL), and the organic layers were extracted with dichloromethane (3 × 20 mL). The organic layers were dried over anhydrous sodium sulfate and concentrated under reduced pressure in vacuo. The crude reaction mixture was purified by silica gel chromatography using EtOAc in hexanes to yield the corresponding sulfonamides in 55−80% yield.
N,N'-(1,2-phenylene)bis(3-chlorobenzenesulfonamide) 7a.
White solid (72%); R f 0.45 (40% EtOAc in hexanes); 1 H NMR (300 MHz, Chloroform-d) δ 7.69 (t, J = 1.9 Hz, 2H), 7.57 (ddt, J = 16.2, 7.9, 1.4 Hz, 4H), 7.40 (t, J = 7.9 Hz, 2H), 7.19-7.04 (m, 4H), 6.98 (dd, . SPR data for CCG-233094 binding to biotinylated HaloTag-Lin28A. In brief, SPR was performed using a SensiQ Pioneer instrument and a BioCap biosensor. The running buffer was 50 mM Tris (pH 7.6), 150 mM NaCl, 1 mM β-mercaptoethanol, 5% glycerol, 0.05% Tween-20, 1 mM ZnCl 2 , and 5% DMSO. The chip was conditioned with 30 µL injections of 1 M sodium chloride in 50 mM sodium hydroxide, a solution of 0.5% sodium dodecyl sulfate, and the running buffer with 1 M of sodium chloride. Protein was immobilized at 2,300 RU. Compounds were tested at 75, 37.5, and 18.7 µM with injection volumes of 50 µL and a flow-rate of 50 µL/min. The chip was regenerated after each cycle with a 10 µL injection of 50 mM Tris (pH 7), 260 mM NaCl, 0.5 mM EDTA, and 0.1% Tween-20. Data was processed using QDAT analysis software. S12 Figure S9 . Representative SPR data for CCG-233094 binding to biotinylated pre-let-7d. As can be seen in the sensorgram, no detectable binding was observed. In brief, SPR was performed using a SensiQ Pioneer instrument and a BioCap biosensor. The running buffer was 50 mM Tris (pH 7.6), 150 mM NaCl, 5% glycerol, 0.05% Tween-20, 1 mM ZnCl 2 , and 5% DMSO. The chip was conditioned with 30 µL injections of 1 M sodium chloride in 50 mM sodium hydroxide, a solution of 0.5% sodium dodecyl sulfate, and the running buffer with 1 M of sodium chloride. Biotinylated pre-let-7d was immobilized at 2,300 RU. Compounds were tested at 100, 50, 25, 12.5, and 6.25 µM with injection volumes of 30 µL and a flow-rate of 30 µL/min. The chip was regenerated after each cycle with a 10 µL injection of 50 mM Tris (pH 7), 260 mM NaCl, 0.5 mM EDTA, and 0.1% Tween-20. Data was processed using QDAT analysis software. 1.1 -4.9
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